Defocad 6 Tablet
By Defocad
Rx
10 Tablet in a Strip

Composition
Deflazacort(6mg)

Manufacturer - Cadila Pharmaceuticals Ltd
Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, INDIA.

Expires on or after
August, 2025

liver
Defocad 6 Tablet is considered safe for use in patients with liver disease. It is important to note that no dose adjustment of Defocad 6 Tablet is necessary in such cases. This means that individuals with liver issues can take this medication as prescribed without the need for any special considerations. It is always advisable to consult with your doctor before using Defocad 6 Tablet, especially if you have liver concerns, to ensure proper guidance and safety.

kidney
Defocad 6 Tablet is considered safe for patients with kidney disease. No dosage adjustments are needed for this medicine in relation to kidney issues.

alcohol
It is not safe to drink alcohol while taking Defocad 6 Tablet. Consulting a doctor is advisable before consuming alcohol with this medication.

driving
Defocad 6 Tablet typically does not impact driving ability.

pregnancy
Defocad 6 Tablet is not recommended during pregnancy due to potential harm to the developing baby based on animal studies. Consult your doctor for a thorough evaluation of benefits and risks before taking this medication.

breastfeeding
Defocad 6 Tablet may be unsafe to use while breastfeeding. Limited data indicates it could pass into breastmilk and harm the baby. It's advisable to consult your doctor before use.
Habit Forming | No |
Chemical Class | Gluco/mineralocorticoids, progestogins and derivatives |
Therapeutic Class | HORMONES |
Action Class | - |
₹77
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 18-Nov-2024